サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1362934

細胞培養の市場規模、シェア、動向分析レポート：製品別、用途別、地域別、セグメント予測、2023年～2030年

Cell Culture Market Size, Share & Trends Analysis Report By Product (Consumables, Instruments), By Application (Biopharmaceutical Production, Diagnostics, Cell & Gene Therapy), By Region, And Segment Forecasts, 2023 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 150 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
細胞培養の市場規模、シェア、動向分析レポート：製品別、用途別、地域別、セグメント予測、2023年～2030年
出版日: 2023年09月07日
発行: Grand View Research
ページ情報: 英文 150 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

細胞培養市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の細胞培養市場規模は2030年までに390億9,000万米ドルに達し、2023年から2030年までのCAGRは11.32％で成長すると予測されています。

新規の三次元細胞培養技術と、バイオ医薬品開発、ワクチン生産におけるニーズの高まり、先端治療医薬品に対する世界の需要の高まりが、予測期間中の市場を牽引すると見られています。COVID-19の大流行により、特に新規mRNAワクチンやDNAワクチンの分野でワクチン開発活動が活発化しています。大規模なワクチン生産は、細胞培養技術を用いて生産されるベクターに対する高い需要を生み出しています。例えば、2023年2月、SKバイオサイエンスは、同社初の細胞培養ベースの4価インフルエンザワクチンであるSKYCellfluが、南米でInstituto de Salud Publica de Chile（公衆衛生研究所、ISP）から正式に認可されたと発表しました。

さらに、ワクチン開発には、細胞ベースのアッセイを使用するいくつかの発現解析、品質管理、安全性試験手順が必要です。その結果、このような用途での細胞培養製品の使用は、近年高い需要を目の当たりにしています。さらに、感染症の発生率の増加、疾病発生の予防への関心の高まり、ワクチン技術への研究開発投資の高さにより、ワクチン生産が牽引力を増し、市場の成長を後押しすると予測されています。バイオ医薬品の分野では、哺乳類細胞を培養できるようになったことで、複雑なタンパク質ベースの医薬品を大量に生産できるようになっています。

このことは、バイオ医薬品業界における効率の向上、コストの削減、品質管理の改善につながっています。さらに、高収率細胞株の上市と培養条件の最適化が、生産性とスケーラビリティの向上に寄与しています。例えば、2023年6月、Matica Bio社はBIO International ConventionでMatiMax細胞株を発表しました。さらに、複数の企業が市場拡大などの戦略的な取り組みを行っており、これが市場成長の要因となっています。例えば、2021年3月、サーモフィッシャーサイエンティフィック社は、2022年までの設備投資に6億米ドルを投資する拡大計画を発表しました。スコットランド、フロリダ、ニューヨークにある同社の細胞培養培地・プロセス液拠点は、ギブコ細胞培養培地、プロセス液、サプリメントの生産能力を増強しました。こうした新興国市場の開発は、予測期間中の市場成長を促進するとみられます。

細胞培養市場レポートハイライト

  • モノクローナル抗体、ワクチン、細胞・遺伝子治療などの先進バイオ医薬品を生産するための製薬・バイオ医薬品企業による研究開発費の増加により、消耗品製品セグメントは2022年に57.44%の最大シェアを占めました。
  • バイオ医薬品生産分野は2022年に32.15%の最大シェアを占めました。バイオテクノロジー分野は拡大が予想され、予測期間中、細胞培養用品と器具の需要を煽る。
  • 北米は2022年に35.90%のシェアで市場を独占しました。この大きなシェアは、同地域の製薬・バイオテクノロジー部門が確立していること、米国で技術的に先進的なソリューションの採用が進んでいることに起因しています。さらに、同地域では複数の大学で大規模な細胞治療研究が行われているため、細胞培養技術市場も大きいです。
  • アジア太平洋地域は、細胞療法や遺伝子療法に対する意識の高まり、再生医療やがん免疫療法などの科学技術や新興治療薬の急速な採用により、予測期間中に13.79%のCAGRで最も急速に拡大すると予測されています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場変数、動向、および範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場促進要因の分析
    • 市場抑制要因分析
  • 業界分析ツール
    • ポーターのファイブフォース分析
    • PESTEL分析
    • COVID-19感染症の影響分析

第4章 製品のビジネス分析

  • 細胞培養市場：製品の変動分析
  • 消耗品
    • 世界の消耗品市場、2018～2030年
    • メディア
    • 血清
    • 試薬
  • 機器
    • 世界の機器市場、2018～2030年
    • 培養システム
    • 保育器
    • 遠心分離機
    • 冷凍保存装置
    • バイオセーフティ機器
    • ピペット器具

第5章 用途のビジネス分析

  • 細胞培養市場：用途の変動分析
  • バイオ医薬品の生産
  • 医薬品開発
  • 診断
  • 組織培養と工学
  • 細胞および遺伝子治療
  • 毒性試験
  • その他の用途

第6章 地域のビジネス分析

  • 地域別の細胞培養市場シェア、2022年および2030年
  • 北米
    • 北米の細胞培養市場、2018年～2030年
    • 米国
    • カナダ
  • 欧州
    • 欧州の細胞培養市場、2018年～2030年
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋地域
    • アジア太平洋の細胞培養市場、2018年～2030年
    • 日本
    • 中国
    • インド
    • オーストラリア
    • タイ
    • 韓国
  • ラテンアメリカ
    • ラテンアメリカの細胞培養市場、2018年～2030年
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • 中東・アフリカの細胞培養市場、2018年～2030年
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 企業の分類
  • 戦略マッピング
  • 企業の市場シェア分析、2022年
  • 企業プロファイル・一覧表
    • Sartorius AG
    • Danaher
    • Merck KGaA
    • Thermo Fisher Scientific, Inc.
    • Corning Inc.
    • Avantor Inc.
    • BD
    • Eppendorf SE
    • Bio-Techne
    • PromoCell GmbH
図表

List of Tables

  • Table 1 Global cell culture market, by region, 2018 - 2030 (USD Million)
  • Table 2 Global cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 3 Global cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 4 North America cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 5 North America cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 6 U.S. cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 7 U.S. cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 8 Canada cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 9 Canada cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 10 Europe cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 11 Europe cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 12 UK cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 13 UK cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 14 Germany cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 15 Germany cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 16 France cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 17 France cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 18 Italy cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 19 Italy cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 20 Spain cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 21 Spain cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 22 Denmark cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 23 Denmark cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 24 Sweden cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 25 Sweden cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 26 Norway cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 27 Norway cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific cell culture market, by application, 2018 - 2030 (USD Millon)
  • Table 30 Japan cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 31 Japan cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 32 China cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 33 China cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 34 India cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 35 India cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 36 Australia cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 37 Australia cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 38 South Korea cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 39 South Korea cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 40 Thailand cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 41 Thailand cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 42 Latin America cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 43 Latin America cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 44 Brazil cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 45 Brazil cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 46 Mexico cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 47 Mexico cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 48 Argentina cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 49 Argentina cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 50 Middle East & Africa cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 51 Middle East & Africa cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 52 South Africa cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 53 South Africa cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 54 Saudi Arabia cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 55 Saudi Arabia cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 56 UAE cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 57 UAE cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 58 Kuwait cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 59 Kuwait cell culture market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Cell culture market segmentation
  • Fig. 2 Data analysis models
  • Fig. 3 Market formulation and validation
  • Fig. 4 Data validating & publishing
  • Fig. 5 Market research process
  • Fig. 6 Information procurement
  • Fig. 7 Primary research
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD modelling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Commodity flow analysis
  • Fig. 12 Market outlook
  • Fig. 13 Segment snapshot
  • Fig. 14 Competitive landscape snapshot
  • Fig. 15 Life science tools market value, 2022 (USD billion)
  • Fig. 16 Market trends & outlook
  • Fig. 17 Number of biologics approved by the U.S. FDA each year from 2015 to 2022
  • Fig. 18 PESTEL analysis
  • Fig. 19 Porter's five forces analysis
  • Fig. 20 Cell culture market: Product outlook & key takeaways
  • Fig. 21 Cell culture market: Product movement analysis
  • Fig. 22 Global consumables market, 2018 - 2030 (USD Million)
  • Fig. 23 Global media market, 2018 - 2030 (USD Million)
  • Fig. 24 Global serum-free media market, 2018 - 2030 (USD Million)
  • Fig. 25 Global CHO media market, 2018 - 2030 (USD Million)
  • Fig. 26 Global BHK medium market, 2018 - 2030 (USD Million)
  • Fig. 27 Global Vero medium market, 2018 - 2030 (USD Million)
  • Fig. 28 Global HEK 293 media market, 2018 - 2030 (USD Million)
  • Fig. 29 Global other serum-free media market, 2018 - 2030 (USD Million)
  • Fig. 30 Global classical media market, 2018 - 2030 (USD Million)
  • Fig. 31 Global stem cell culture media market, 2018 - 2030 (USD Million)
  • Fig. 32 Global specialty media market, 2018 - 2030 (USD Million)
  • Fig. 33 Global chemically defined media market, 2018 - 2030 (USD Million)
  • Fig. 34 Global other cell culture media market, 2018 - 2030 (USD Million)
  • Fig. 35 Global sera market, 2018 - 2030 (USD Million)
  • Fig. 36 Global fetal bovine serum market, 2018 - 2030 (USD Million)
  • Fig. 37 Global others market, 2018 - 2030 (USD Million)
  • Fig. 38 Global reagents market, 2018 - 2030 (USD Million)
  • Fig. 39 Global albumin market, 2018 - 2030 (USD Million)
  • Fig. 40 Global others market, 2018 - 2030 (USD Million)
  • Fig. 41 Global instruments market, 2018 - 2030 (USD Million)
  • Fig. 42 Global culture systems market, 2018 - 2030 (USD Million)
  • Fig. 43 Global incubators market, 2018 - 2030 (USD Million)
  • Fig. 44 Global centrifuges market, 2018 - 2030 (USD Million)
  • Fig. 45 Global cryostorage equipment market, 2018 - 2030 (USD Million)
  • Fig. 46 Global biosafety equipment market, 2018 - 2030 (USD Million)
  • Fig. 47 Global pipetting instruments market, 2018 - 2030 (USD Million)
  • Fig. 48 Cell culture market: Application outlook key takeaways
  • Fig. 49 Cell culture market: Application movement analysis
  • Fig. 50 Global biopharmaceutical production market, 2018 - 2030 (USD Million)
  • Fig. 51 Global monoclonal antibodies market, 2018 - 2030 (USD Million)
  • Fig. 52 Global vaccines production market, 2018 - 2030 (USD Million)
  • Fig. 53 Global other therapeutic proteins market, 2018 - 2030 (USD Million)
  • Fig. 54 Global drug development market, 2018 - 2030 (USD Million)
  • Fig. 55 Global diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 56 Global tissue culture & engineering market, 2018 - 2030 (USD Million)
  • Fig. 57 Global cell and gene therapy market, 2018 - 2030 (USD Million)
  • Fig. 58 Global toxicity testing market, 2018 - 2030 (USD Million)
  • Fig. 59 Global other applications market, 2018 - 2030 (USD Million)
  • Fig. 60 Regional outlook
  • Fig. 61 Regional marketplace: Key takeaways
  • Fig. 62 North America cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 U.S. cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 Canada cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Europe cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 Germany cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 UK cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 France cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Italy cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 Spain cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 Denmark cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 Key country dynamics
  • Fig. 81 Sweden cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Key country dynamics
  • Fig. 83 Norway cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 Asia Pacific cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 Japan cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 87 Key country dynamics
  • Fig. 88 China cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 89 Key country dynamics
  • Fig. 90 India cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 91 Key country dynamics
  • Fig. 92 Australia cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 93 Key country dynamics
  • Fig. 94 Thailand cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 95 Key country dynamics
  • Fig. 96 South Korea cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 97 Latin America cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 98 Key country dynamics
  • Fig. 99 Brazil cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 100 Key country dynamics
  • Fig. 101 Mexico cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 102 Key country dynamics
  • Fig. 103 Argentina cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 104 MEA cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 105 Key country dynamics
  • Fig. 106 South Africa cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 107 Key country dynamics
  • Fig. 108 Saudi Arabia cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 109 Key country dynamics
  • Fig. 110 UAE cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 111 Key country dynamics
  • Fig. 112 Kuwait cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 113 Market participant categorization
  • Fig. 114 Global cell culture market share analysis, 2022
  • Fig. 115 Strategic framework
目次
Product Code: 978-1-68038-536-6

Cell Culture Market Growth & Trends:

The global cell culture market size is expected to reach USD 39.09 billion by 2030 and is expected to grow at a CAGR of 11.32% from 2023 to 2030, according to a new report by Grand View Research, Inc.. The novel three-dimensional cell culture techniques and the growing need for them in biopharmaceutical development, vaccine production, and the rising global demand for advanced therapy medicinal products are expected to drive the market during the forecast period. The COVID-19 pandemic has increased vaccine development activities, especially in the novel mRNA and DNA vaccines space. Vaccine production at a large scale generates a high demand for vectors produced using cell culture techniques. For instance, in February 2023, SK Bioscience announced that its first cell culture-based quadrivalent influenza vaccine, SKYCellflu, was officially licensed in South America by Instituto de Salud Publica de Chile (Institute of Public Health, ISP).

Furthermore, vaccine development requires several expression analyses, quality control, and safety testing procedures, which use cell-based assays. As a result, the usage of cell culture products for such applications has witnessed high demand in recent years. In addition, with an increase in the incidence of infectious diseases, a rise in focus on prevention of disease outbreaks, and high R&D investments in vaccine technologies, vaccine production is projected to gain traction and boost market growth.Moreover, cell culture technology has witnessed significant advancements over the past few years and the technology is witnessing a rapid expansion in its scope of applications. In the field of biopharmaceuticals, researchers can now produce complex protein-based drugs in large quantities due to the ability to culture mammalian cells.

This has led to increased efficiency, reduced costs, and improved quality control in the biopharmaceutical industry. Furthermore, the launch of high-yield cell lines and the optimization of culture conditions have contributed to enhanced productivity and scalability. For instance, in June 2023, Matica Bio launched its MatiMax cell lines at the BIO International Convention.Furthermore, several companies are engaged in strategic initiatives, such as market expansion, which can be attributed to market growth. For instance, in March 2021, Thermo Fisher Scientific, Inc. announced its expansion plans by investing USD 600 million into capital investments through 2022. Its cell culture media and process liquid sites in Scotland, Florida, and New York increased the production capacity of Gibco cell culture media, process liquids, and supplements. Such developments are expected to propel the market growth over the forecast period.

Cell Culture Market Report Highlights:

  • The consumables product segment accounted for the largest share of 57.44% in 2022 due to increased R&D spending by pharmaceutical & biopharmaceutical businesses to produce advanced biopharmaceuticals, such as monoclonal antibodies, vaccines, and cell & gene therapies
  • The biopharmaceutical production segment accounted for the largest share of 32.15% in 2022. The biotechnology sector is anticipated to expand, fueling demand for cell culture supplies and instruments over the forecast period
  • North America dominated the market with a share of 35.90% in 2022. The large share can be attributed to the region's well-established pharmaceutical & biotech sectors and higher adoption of technologically advanced solutions in the U.S. In addition, there is a large market for cell culture technologies in the region due to the extensive cell therapy research efforts undertaken by several universities
  • Asia Pacific is projected to expand at the fastest CAGR of 13.79% over the forecast period due to the rising awareness regarding cell and gene therapies, and the rapid adoption of scientific technologies and emerging therapeutics, such as regenerative medicines and cancer immunotherapies

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Product Segment
      • 1.1.1.2. Application Segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objective
    • 1.4.1. Objective 1
    • 1.4.2. Objective2
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information or Data Analysis:
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List of Secondary Sources
  • 1.11. List of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Expansion in the scope of cell culture technology
      • 3.2.1.2. Rising demand for biopharmaceuticals, artificial organs, & vaccine production
      • 3.2.1.3. Growth in demand for serum-free, specialty, and customized media
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Stringent process control in cell culture techniques
      • 3.2.2.2. Scalability issues with culturing methods
      • 3.2.2.3. Ethical concerns regarding use of animals
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Product Business Analysis

  • 4.1. Cell Culture Market: Product Movement Analysis
  • 4.2. Consumables
    • 4.2.1. Global Consumables Market, 2018 - 2030 (USD Million)
    • 4.2.2. Media
      • 4.2.2.1. Global media market, 2018 - 2030 (USD million)
      • 4.2.2.2. Serum-free media
      • 4.2.2.2.1. Global serum-free media market, 2018 - 2030 (USD million)
      • 4.2.2.2.2. CHO media
      • 4.2.2.2.2.1. Global CHO media market, 2018 - 2030 (USD million)
      • 4.2.2.2.3. BHK medium
      • 4.2.2.2.3.1. Global BHK medium market, 2018 - 2030 (USD million)
      • 4.2.2.2.4. Vero medium
      • 4.2.2.2.4.1. Global Vero medium market, 2018 - 2030 (USD million)
      • 4.2.2.2.5. HEK 293 Media
      • 4.2.2.2.5.1. Global HEK 293 media market, 2018 - 2030 (USD million)
      • 4.2.2.2.6. Other serum-free media
      • 4.2.2.2.6.1. Global other serum-free media market, 2018 - 2030 (USD million)
      • 4.2.2.3. Classical media
      • 4.2.2.3.1. Global classical media market, 2018 - 2030 (USD million)
      • 4.2.2.4. Stem cell culture media
      • 4.2.2.4.1. Global stem cell culture media market, 2018 - 2030 (USD million)
      • 4.2.2.5. Specialty media
      • 4.2.2.5.1. Global specialty media market, 2018 - 2030 (USD million)
      • 4.2.2.6. Chemically defined media
      • 4.2.2.6.1. Global chemically defined media market, 2018 - 2030 (USD million)
      • 4.2.2.7. Other cell culture media
      • 4.2.2.7.1. Global other cell culture media market, 2018 - 2030 (USD million)
    • 4.2.3. Sera
      • 4.2.3.1. Global sera market, 2018 - 2030 (USD million)
      • 4.2.3.2. Fetal bovine serum
      • 4.2.3.2.1. Global fetal bovine serum market, 2018 - 2030 (USD million)
      • 4.2.3.3. Others
      • 4.2.3.3.1. Global others market, 2018 - 2030 (USD million)
    • 4.2.4. Reagents
      • 4.2.4.1. Global reagents market, 2018 - 2030 (USD million)
      • 4.2.4.2. Albumin
      • 4.2.4.2.1. Global albumin market, 2018 - 2030 (USD million)
      • 4.2.4.3. Others
      • 4.2.4.3.1. Global others market, 2018 - 2030 (USD million)
  • 4.3. Instruments
    • 4.3.1. Global instruments market, 2018 - 2030 (USD million)
    • 4.3.2. Culture systems
      • 4.3.2.1. Global culture systems market, 2018 - 2030 (USD million)
    • 4.3.3. Incubators
      • 4.3.3.1. Global incubators market, 2018 - 2030 (USD million)
    • 4.3.4. Centrifuges
      • 4.3.4.1. Global centrifuges market, 2018 - 2030 (USD million)
    • 4.3.5. Cryostorage equipment
      • 4.3.5.1. Global cryostorage equipment market, 2018 - 2030 (USD million)
    • 4.3.6. Biosafety equipment
      • 4.3.6.1. Global biosafety equipment market, 2018 - 2030 (USD million)
    • 4.3.7. Pipetting instruments
      • 4.3.7.1. Global pipetting instruments market, 2018 - 2030 (USD million)

Chapter 5. Application Business Analysis

  • 5.1. Cell Culture Market: Application Movement Analysis
  • 5.2. Biopharmaceutical Production
    • 5.2.1. Global Biopharmaceutical Production Market, 2018 - 2030 (USD Million)
    • 5.2.2. Monoclonal antibodies
      • 5.2.2.1. Monoclonal antibodies market, 2018 - 2030 (USD million)
    • 5.2.3. Vaccines production
      • 5.2.3.1. Global vaccines production market, 2018 - 2030 (USD million)
    • 5.2.4. Other therapeutic proteins
      • 5.2.4.1. Global other therapeutic proteins market, 2018 - 2030 (USD million)
  • 5.3. Drug Development
    • 5.3.1. Global drug development market, 2018 - 2030 (USD Million)
  • 5.4. Diagnostics
    • 5.4.1. Global diagnostics market, 2018 - 2030 (USD Million)
  • 5.5. Tissue Culture & Engineering
    • 5.5.1. Global tissue culture & engineering, 2018 - 2030 (USD Million)
  • 5.6. Cell & Gene Therapy
    • 5.6.1. Global cell and gene therapy market, 2018 - 2030 (USD million)
  • 5.7. Toxicity Testing
    • 5.7.1. Global toxicity testing market, 2018 - 2030 (USD million)
  • 5.8. Other Applications
    • 5.8.1. Global other applications market, 2018 - 2030 (USD million)

Chapter 6. Regional Business Analysis

  • 6.1. Cell Culture Market Share By Region, 2022 & 2030
  • 6.2. North America
    • 6.2.1. North America Cell Culture Market, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. Key Country Dynamics
      • 6.2.2.2. Competitive Scenario
      • 6.2.2.3. Regulatory Framework
      • 6.2.2.4. U.S. Cell Culture Market, 2018 - 2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Key Country Dynamics
      • 6.2.3.2. Competitive Scenario
      • 6.2.3.3. Regulatory Framework
      • 6.2.3.4. Canada Cell Culture Market, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Cell Culture Market, 2018 - 2030 (USD Million)
    • 6.3.2. UK
      • 6.3.2.1. Key Country Dynamics
      • 6.3.2.2. Competitive Scenario
      • 6.3.2.3. Regulatory Framework
      • 6.3.2.4. UK Cell Culture Market, 2018 - 2030 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Key Country Dynamics
      • 6.3.3.2. Competitive Scenario
      • 6.3.3.3. Regulatory Framework
      • 6.3.3.4. Germany Cell Culture Market, 2018 - 2030 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. Key Country Dynamics
      • 6.3.4.2. Competitive Scenario
      • 6.3.4.3. Regulatory Framework
      • 6.3.4.4. France Cell Culture Market, 2018 - 2030 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Key Country Dynamics
      • 6.3.5.2. Competitive Scenario
      • 6.3.5.3. Regulatory Framework
      • 6.3.5.4. Italy Cell Culture Market, 2018 - 2030 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Key Country Dynamics
      • 6.3.6.2. Competitive Scenario
      • 6.3.6.3. Regulatory Framework
      • 6.3.6.4. Spain Cell Culture Market, 2018 - 2030 (USD Million)
    • 6.3.7. Denmark
      • 6.3.7.1. Key Country Dynamics
      • 6.3.7.2. Competitive Scenario
      • 6.3.7.3. Regulatory Framework
      • 6.3.7.4. Denmark Cell Culture Market, 2018 - 2030 (USD Million)
    • 6.3.8. Sweden
      • 6.3.8.1. Key Country Dynamics
      • 6.3.8.2. Competitive Scenario
      • 6.3.8.3. Regulatory Framework
      • 6.3.8.4. Sweden Cell Culture Market, 2018 - 2030 (USD Million)
    • 6.3.9. Norway
      • 6.3.9.1. Key Country Dynamics
      • 6.3.9.2. Competitive Scenario
      • 6.3.9.3. Regulatory Framework
      • 6.3.9.4. Norway Cell Culture Market, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Cell Culture Market, 2018 - 2030 (USD Million)
    • 6.4.2. Japan
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Competitive Scenario
      • 6.4.2.3. Regulatory Framework
      • 6.4.2.4. Japan Cell Culture Market, 2018 - 2030 (USD Million)
    • 6.4.3. China
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Competitive Scenario
      • 6.4.3.3. Regulatory Framework
      • 6.4.3.4. China Cell Culture Market, 2018 - 2030 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Competitive Scenario
      • 6.4.4.3. Regulatory Framework
      • 6.4.4.4. India Cell Culture Market, 2018 - 2030 (USD Million)
    • 6.4.5. Australia
      • 6.4.5.1. Key Country Dynamics
      • 6.4.5.2. Competitive Scenario
      • 6.4.5.3. Regulatory Framework
      • 6.4.5.4. Australia Cell Culture Market, 2018 - 2030 (USD Million)
    • 6.4.6. Thailand
      • 6.4.6.1. Key Country Dynamics
      • 6.4.6.2. Competitive Scenario
      • 6.4.6.3. Regulatory Framework
      • 6.4.6.4. Thailand Cell Culture Market, 2018 - 2030 (USD Million)
    • 6.4.7. South Korea
      • 6.4.7.1. Key Country Dynamics
      • 6.4.7.2. Competitive Scenario
      • 6.4.7.3. Regulatory Framework
      • 6.4.7.4. South Korea Cell Culture Market, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Cell Culture Market, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Competitive Scenario
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. Brazil Cell Culture Market, 2018 - 2030 (USD Million)
    • 6.5.3. Mexico
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Competitive Scenario
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. Mexico Cell Culture Market, 2018 - 2030 (USD Million)
    • 6.5.4. Argentina
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Competitive Scenario
      • 6.5.4.3. Regulatory Framework
      • 6.5.4.4. Argentina Cell Culture Market, 2018 - 2030 (USD Million)
  • 6.6. MEA
    • 6.6.1. MEA Cell Culture Market, 2018 - 2030 (USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Competitive Scenario
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. South Africa Cell Culture Market, 2018 - 2030 (USD Million)
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Competitive Scenario
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. Saudi Arabia Cell Culture Market, 2018 - 2030 (USD Million)
    • 6.6.4. UAE
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Competitive Scenario
      • 6.6.4.3. Regulatory Framework
      • 6.6.4.4. UAE Cell Culture Market, 2018 - 2030 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Competitive Scenario
      • 6.6.5.3. Regulatory Framework
      • 6.6.5.4. Kuwait Cell Culture Market, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company Categorization
  • 7.2. Strategy Mapping
  • 7.3. Company Market Share Analysis, 2022
  • 7.4. Company Profiles/Listing
    • 7.4.1. Sartorius AG
      • 7.4.1.1. Overview
      • 7.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Strategic Initiatives
    • 7.4.2. Danaher
      • 7.4.2.1. Overview
      • 7.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Strategic Initiatives
    • 7.4.3. Merck KGaA
      • 7.4.3.1. Overview
      • 7.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Strategic Initiatives
    • 7.4.4. Thermo Fisher Scientific, Inc.
      • 7.4.4.1. Overview
      • 7.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Strategic Initiatives
    • 7.4.5. Corning Inc.
      • 7.4.5.1. Overview
      • 7.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Strategic Initiatives
    • 7.4.6. Avantor Inc.
      • 7.4.6.1. Overview
      • 7.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Strategic Initiatives
    • 7.4.7. BD
      • 7.4.7.1. Overview
      • 7.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Strategic Initiatives
    • 7.4.8. Eppendorf SE
      • 7.4.8.1. Overview
      • 7.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Strategic Initiatives
    • 7.4.9. Bio-Techne
      • 7.4.9.1. Overview
      • 7.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Strategic Initiatives
    • 7.4.10. PromoCell GmbH
      • 7.4.10.1. Overview
      • 7.4.10.2. Product Benchmarking
      • 7.4.10.3. Strategic Initiatives